Literature DB >> 22862299

Prospective cohort study about the lymphocyte subpopulations' change and impact on the pregnancy outcome in fetal growth restriction.

Fei Xiong1, Yu Tong, Yong You, Ping Li, Tingzhu Huo, Wenwei Tu, Meng Mao.   

Abstract

OBJECTIVE: To evaluate lymphocyte subpopulations' change and impact on the pregnancy outcome in fetal growth restriction (FGR) through a prospective cohort study.
METHODS: Sixty singleton pregnancies with FGR and 20 normal pregnant women were enrolled at the third trimester of pregnancy in this study. FGR was defined according to fundal height and abdominal circumference through obstetric examination and ultrasound examination. Third trimester peripheral blood and umbilical cord blood lymphocyte subpopulations were analysed by flow cytometry. The cytotoxic activity of lymphocytes using umbilical cord blood mononuclear activated kill cells as the effector cells, K562 cells as the target cells was measured by MTT deoxidation assay.
RESULTS: There were no significant differences about the age, parity, gestational age enrolled, BMI before pregnancy between the FGR and control group. The birth weight, length and head circumference of the neonates from FGR group were less than that from normal control. The percentages of B-lymphocytes in peripheral blood at the third trimester were significantly increased in FGR group compared to that in control group (P < 0.05). In umbilical cord blood, FGR group had a higher percentage of both CD3 and CD4 lymphocyte, lower absolute cell counts and percentage of B-lymphocyte, and higher CD4/CD8 ratio than control group (P < 0.05). Most importantly, the kill cell activity of the lymphocytes in cord blood from FGR group was significantly higher than that from control group (P < 0.05). The significant positive correlations were also found that the percentage and number of B lymphocytes in umbilical cord blood with birthweight, birthlength and birth head circumference, but CD4/CD8 ratio, the kill cell activity in umbilical cord blood had negative correlations with that. The percentage of B lmyphocyte in third trimester and CD4/CD8 ratio, kill cell activity in umbilical cord blood are associated with an increased risk of prematurity and SGA birth, but contrary result was found with the percentage and number of B lmyphocyte in cord blood.
CONCLUSIONS: Fetal immunological rejection could be involved in the pathogenesis of FGR. The changes of T lymphocyte subpopulations and B-cells, enhanced kill cell activity might cause FGR and preterm birth.

Entities:  

Mesh:

Year:  2012        PMID: 22862299     DOI: 10.3109/14767058.2012.715219

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

1.  Altered immune system in offspring of rat maternal vertical sleeve gastrectomy.

Authors:  Redin A Spann; Erin B Taylor; Bradley A Welch; Bernadette E Grayson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-11-06       Impact factor: 3.619

2.  Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional study.

Authors:  Deepak K Rathore; Deepa Nair; Saimah Raza; Savita Saini; Reeta Singh; Amit Kumar; Reva Tripathi; Siddarth Ramji; Aruna Batra; Kailash C Aggarwal; Harish K Chellani; Sugandha Arya; Neerja Bhatla; Vinod K Paul; Ramesh Aggarwal; Nidhi Agarwal; Umesh Mehta; Shailaja Sopory; Uma Chandra Mouli Natchu; Shinjini Bhatnagar; Vineeta Bal; Satyajit Rath; Nitya Wadhwa
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

3.  Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells.

Authors:  Andrea I Loewendorf; Tina A Nguyen; Maria N Yesayan; Daniel A Kahn
Journal:  Am J Reprod Immunol       Date:  2015-05-10       Impact factor: 3.886

4.  Thyroid Autoimmunity is Associated with Decreased Cytotoxicity T Cells in Women with Repeated Implantation Failure.

Authors:  Chunyu Huang; Peiyan Liang; Lianghui Diao; Cuicui Liu; Xian Chen; Guangui Li; Cong Chen; Yong Zeng
Journal:  Int J Environ Res Public Health       Date:  2015-08-25       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.